Published in Addiction on February 01, 2010
Improving Access to Long-Acting Contraceptive Methods and Reducing Unplanned Pregnancy Among Women with Substance Use Disorders. Subst Abuse (2016) 0.92
Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users. Am J Public Health (2015) 0.79
Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review. Front Psychiatry (2012) 0.78
Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia. J Urban Health (2012) 0.76
The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals? PLoS One (2016) 0.75
Health care workers in Pearl River Delta Area of China are not vaccinated adequately against hepatitis B: a retrospective cohort study. BMC Infect Dis (2015) 0.75
Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users. Int J Environ Res Public Health (2015) 0.75
Unplanned admissions to two Sydney public hospitals after naltrexone implants. Med J Aust (2008) 3.98
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet (2007) 3.62
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. Br J Psychiatry (2013) 2.62
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Med J Aust (2003) 2.04
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology (2009) 1.99
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain (2015) 1.62
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis (2004) 1.54
Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med (2014) 1.49
Overview of substance use and treatment from Australia. Subst Abus (2014) 1.45
A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia. Addiction (2003) 1.41
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction (2006) 1.24
The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy (2011) 1.23
SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. J Biochem Biophys Methods (2003) 1.23
Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol Alcohol (2006) 1.19
Health assessment of artisanal gold miners in Tanzania. Sci Total Environ (2009) 1.16
An overview of the patterns of prescription opioid use, costs and related harms in Australia. Br J Clin Pharmacol (2014) 1.16
Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol (2011) 1.10
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study. Clin Infect Dis (2013) 1.09
Intrahepatic gene expression in human alcoholic hepatitis. J Hepatol (2006) 1.08
Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. Am J Pathol (2003) 1.08
The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care (2012) 1.05
Harm reduction healthcare: from an alternative to the mainstream platform? Int J Drug Policy (2010) 1.05
Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health (2004) 1.03
Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol (2012) 1.00
Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev (2010) 0.99
"Should I stay or should I go?" Coming off methadone and buprenorphine treatment. Int J Drug Policy (2010) 0.99
Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Med J Aust (2010) 0.98
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. J Hepatol (2010) 0.98
Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol (2008) 0.98
The health impacts of khat: a qualitative study among Somali-Australians. Med J Aust (2011) 0.97
Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug Alcohol Rev (2008) 0.97
Inflammation and repair in viral hepatitis C. Dig Dis Sci (2008) 0.94
Real-time monitoring of Schedule 8 medicines in Australia: evaluation is essential. Med J Aust (2013) 0.91
Confidentiality and autonomy: the challenge(s) of offering research participants a choice of disclosing their identity. Qual Health Res (2007) 0.90
Alcohol, signaling, and ECM turnover. Alcohol Clin Exp Res (2009) 0.89
A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med (2013) 0.88
Aminopeptidase O contains a functional nucleolar localization signal and is implicated in vascular biology. J Cell Biochem (2008) 0.88
Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. J Subst Abuse Treat (2008) 0.87
Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug Alcohol Rev (2007) 0.87
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. J Gastroenterol Hepatol (2012) 0.86
Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. J Subst Abuse Treat (2012) 0.86
Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria. Aust N Z J Public Health (2009) 0.86
Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose. Med J Aust (2002) 0.86
Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology (2010) 0.85
The effectiveness of a tailored intervention for excessive alcohol consumption prior to elective surgery. Alcohol Alcohol (2006) 0.85
International perspectives in postgraduate medical training in addiction medicine. Subst Abus (2011) 0.84
Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009. AIDS (2011) 0.84
Detection of and intervention for excessive alcohol and tobacco use among adult hospital in-patients. Drug Alcohol Rev (2007) 0.84
Genetic control of grain yield and grain physical characteristics in a bread wheat population grown under a range of environmental conditions. Theor Appl Genet (2014) 0.84
Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project. Addict Behav (2005) 0.84
Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia? Drug Alcohol Rev (2011) 0.83
Bioavailability of buprenorphine from crushed and whole buprenorphine (subutex) tablets. Eur Addict Res (2010) 0.83
Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Aust J Prim Health (2011) 0.83
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation. Med J Aust (2009) 0.83
The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial. J Stud Alcohol (2005) 0.83
Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depend (2003) 0.83
Psychosocial characteristics and obstetric health of women attending a specialist substance use antenatal clinic in a large metropolitan hospital. Int J Pediatr (2011) 0.83
Brief report: genetics of alcoholic cirrhosis-GenomALC multinational study. Alcohol Clin Exp Res (2015) 0.83
Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev (2016) 0.82
The hepatic transcriptome in human liver disease. Comp Hepatol (2006) 0.82
Factors influencing pharmacy services in opioid substitution treatment. Drug Alcohol Rev (2013) 0.82
Do elective surgery patients use the internet to look for information about their condition? ANZ J Surg (2004) 0.82
The influence of alcohol and tobacco use in orthopaedic inpatients on complications of surgery. Drug Alcohol Rev (2008) 0.82
Effectiveness of skills-based training using the Drink-less package to increase family practitioner confidence in intervening for alcohol use disorders. BMC Med Educ (2006) 0.82
Exercise increases plasma THC concentrations in regular cannabis users. Drug Alcohol Depend (2013) 0.82
The medical complications of heroin use. Curr Opin Psychiatry (2005) 0.81
Induction of hematopoietic differentiation of mouse embryonic stem cells by an AGM-derived stromal cell line is not further enhanced by overexpression of HOXB4. Stem Cells Dev (2010) 0.81
Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology (Berl) (2014) 0.81
Defining a service for people who use drugs as 'low-threshold': what should be the criteria? Int J Drug Policy (2013) 0.81
Correlates of pain in an in-treatment sample of opioid-dependent people. Drug Alcohol Rev (2013) 0.80
Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug Alcohol Rev (2013) 0.80
The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended. Addiction (2008) 0.80
Understanding and treating patients with alcoholic cirrhosis: an update. Alcohol Clin Exp Res (2009) 0.80
Reluctant to train, reluctant to prescribe: barriers to general practitioner prescribing of opioid substitution therapy. Aust J Prim Health (2012) 0.80
Pre-operative screening for excessive alcohol consumption among patients scheduled for elective surgery. Drug Alcohol Rev (2007) 0.79
Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study. Contemp Clin Trials (2009) 0.79
Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence. Drug Alcohol Rev (2009) 0.79
The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Med J Aust (2013) 0.79
Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial. Addict Sci Clin Pract (2013) 0.79
Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample. Drug Alcohol Rev (2013) 0.79
An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners. Pain Med (2012) 0.79
Estimation of the bioaccessible arsenic fraction in soils using near infrared spectroscopy. J Environ Sci Health A Tox Hazard Subst Environ Eng (2007) 0.78
Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation. Drug Alcohol Rev (2010) 0.78
Down-regulation of liver Galbeta1, 4GlcNAc alpha2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans. Metabolism (2008) 0.78
Improving alcohol and tobacco history taking by junior medical officers. Alcohol Alcohol (2008) 0.78
Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug Alcohol Rev (2010) 0.78
Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer. Acta Oncol (2013) 0.77
An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy. Drug Alcohol Rev (2013) 0.77
Clinical predictors of outcome from an Australian pharmacological relapse prevention trial. Alcohol Alcohol (2010) 0.77
Can digitally reconstructed radiographs (DRRS) replace simulation films in prostate cancer conformal radiotherapy? Int J Radiat Oncol Biol Phys (2003) 0.77